Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters

Related articles

1. Fusion protein pan-sarbecovirus vaccines elicit broadly protective immune responses targeting Clade 1a, 1b, and 3 sarbecoviruses

   This article has 28 authors:

   1. Alyson Kelvin
   2. Matthew Rogers
   3. Zahed Katooni
   4. Eva-Maria Uhlemann
   5. Rachelle Buchanan
   6. Erin Scruten
   7. Anthony Yourkowski
   8. Jocelyne Lew
   9. Akarin Asavajaru
   10. Jill Van Kessel
   11. Paul Pennington
   12. Andrea Kroeker
   13. Cynthia Swan
   14. Rinku Patel
   15. Brittany Thivierge
   16. Willian Deck
   17. Ravendra Garg
   18. Glenn Hamonic
   19. Wolfgang Koster
   20. Tracy Prysliak
   21. Anne-Catherine Fluckiger
   22. Jasminka Bozic
   23. Andrew Van Kessel
   24. Volker Gerdts
   25. Qiang Liu
   26. Arinjay Banerjee
   27. Darryl Falzarano
   28. Trina Racine

2. Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins

   This article has 30 authors:

   1. Jalees Rehman
   2. Marcin Kwissa
   3. Manikannan Mathayan
   4. Satyajeet Salunkhe
   5. Velavan Bakthavachalam
   6. Zijing Ye
   7. Mark Sanborn
   8. Samantha Condo
   9. Aditi Upadhye
   10. Athulith Nemakal
   11. Haoyang Wang
   12. James Chan
   13. Justin Richner
   14. Sanjib Basu
   15. Richard Novak
   16. Jeffrey Jacobson
   17. Balaji Ganesh
   18. Martha Cerda
   19. Hassan Brim
   20. Nathaniel Erdmann
   21. Bruce Levy
   22. Gailen Marshall
   23. Grace McComsey
   24. Torri Metz
   25. Megumi Okumura
   26. Michael Peluso
   27. Tiffany Walker
   28. Paul Utz
   29. Jerry Krishnan
   30. Bellur Prabhakar

3. Do mRNA vaccines accelerate the progression of chronic kidney disease? For six years experience

   This article has 2 authors:

   1. Türker EMRE
   2. Fatoş METE